Home | About FPMPAM | FPMPAM Committee | From The President | In The News | Events | Outreach Programmes | Newsletter | Affiliates
2014 Federation of Private Medical Practitioners’ Associations, Malaysia
Published: 27 October 2014
PETALING JAYA: The Federation of Private Medical Practitioner's Associations Malaysia strongly disagreed with the statement from Deputy Finance Minister Datuk Ahmad Maslan that private hospitals and clinics have no reason to raise prices after implementation of Goods and Services Tax (GST) next year.
Its president, Dr Steven Chow, said operating expenses for private clinics will definitely increase with the GST implementation.
"While certain medicines and medical equipment are zero-rated, other parts of the supply chain for private healthcare facilities are not tax-exempt," he said in a statement.
He pointed out that private healthcare does not operate in silos and therefore it is also affected by the cost of items such as rental, water and electricity.
"Costs of medicines are only a small part of a clinic's operating costs and furthermore, only medicines on the government essential drug list are zero-rated, which does not cover the full range of medications used in private and public healthcare," he said.
Chow said while certain medical equipment are GST-exempt, they are not items that are purchased daily.
"Disposables, service and maintenance cost of these equipment and all items associated with the use of the equipment are items that are going to be affected by GST," he said.
"Despite doctor' professional fees remaining the same even after GST, the overall cost of providing the same service will go up.
"We estimate that this will be from 3% to 5%. Therefore, it is incorrect to project that cost will not go up in private clinics and hospitals," he added.
Chow said doctors are left with the option to either increase their fees or absorb any increment in their expenses following the rise in operating costs.
Originally published in thesundaily.my
http://www.thesundaily.my/news/1209721
5th FPMPAM ASC
Details >>
FPMPAM / AMAM Joint ASM 2023
Details >>
JA Assure Partners FPMPAM To Offer Professional Indemnity Insurance Platform To All Medical Professionals Of FPMPAM
Details >>
Covid Fight: Private docs played key role
Details >>
BIOLOGIC ADVISORY GROUP MY: Consensus Guidelines in Usage of Biologics in Dermatology during Covid-19 Pandemic
Details >>
MOH Circular - Quarantine Process for General Practitioners
Details >>
Handbook of 2019-nCoV Pneumonia Control and Prevention
Details >>
Edaran Kemaskini Guidelines on 2019 Novel Coronavirus Management in Malaysia
Details >>
Implementation of Data Breach Notification
Details >>
Guidelines on Continuing Professional Development (CPD) for Medical Practitioners In Malaysia
Download >>
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>
Joint Integrated Healthcare Committee (JIHC) Term Sheet
Click here >>
Joint Integrated Healthcare Committee (JIHC) Terms of Reference
Click here >>
National Pharmaceutical Regulatory Agency
Click here >>
NPRA: Reporting medicinal problems
Click here >>
Makluman Kontraindikasi Penggunaan Ubat Yang Mengandungi Codeine Untuk Kanak-Kanak Beumur Bawah 12 Tahun Dan Ibu Yang Menyusu Susulan Risiko Respiratory Depression
Click here >>
Peringatan: Langkah-Langkah Pengurangan Risiko Bagi Kesan Advers Kulit Tang Serius Susulan Penggunaan Allopurinol
Click here >>
VALPROATE
Guide for HCP >>
Patient Information >>
Sodium Valproate (Guide for HCP) >>
NDST Report 2011
Click here >>
Garis Panduan Pemantauan Keselamatan Produk ESAs dan Pelaporan Kesan Advers PRCA
Click here >>
Report On Suspected Adverse Drug Reactions
Click here >>
MADRAC Newsletter Vol 26 Issue 2 / 2018
Read >>
MADRAC KE 146 - Traditional Medicine found Adulterated
Read >>
BPFK website: Cancellation of Registered Traditional Products / Notified Cosmetics
Read >>
Pharmacy Services Division: List of Adulterated Products
Read >>
Pharmacy Services Division: Press Releases
Read >>